CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Second Sight Medical Products Inc  (EYES)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Equipment & Supplies
 
 

EYES's Revenue Year on Year Growth by Quarter and Year

Second Sight Medical Products Inc's Revenue results by quarter and year



Select the Comparisons : Select the Ratio:                        
EYES Revenue (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter December - 1.77 2.36 0.00
III Quarter September - 1.18 2.23 0.00
II Quarter June 2.24 1.04 2.66 0.00
I Quarter March 1.01 - 1.70 0.00
FY   3.25 3.99 8.95 -

Financial Statements
Second Sight Medical Products Inc's second quarter 2017 Revenue $ 2.24 millions EYES's Income Statement
Second Sight Medical Products Inc's second quarter 2016 Revenue $ 1.04 millions Quarterly EYES's Income Statement
EYES's Growth by Division See EYES's Growth by Segment

EYES Revenue ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter December - -25 % - -
III Quarter September - -47.09 % - -
II Quarter June 115 % -60.9 % - -
I Quarter March - - - -
FY   - -55.42 % - -



EYES Revenue Growth Comment
Second Sight Medical Products Inc reported Revenue surge of 115% year on year in the second quarter, to $ 2.24 millions, this is lower than Second Sight Medical Products Inc's recent average Revenue surge of 15933.99%.

Looking into second quarter results within Medical Equipment & Supplies industry 7 other companies have achieved higher Revenue growth. While Second Sight Medical Products Inc' s Revenue doubling of 115% ranks overall at the positon no. 174 in the second quarter.



Revenue Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #8
Healthcare Sector #46
Overall #174
Revenue Y/Y Growth Statistics
High Average Low
95721.46 % 15933.99 % -99.94 %
(Mar 31 2017)   (Mar 31 2016)

You need to upgrade your Flash Player

Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
EYES's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for EYES's Competitors
Revenue Growth for Second Sight Medical Products Inc's Suppliers
Revenue Growth for EYES's Customers

You may also want to know
EYES's Annual Growth Rates EYES's Profitability Ratios EYES's Asset Turnover Ratio EYES's Dividend Growth
EYES's Roe EYES's Valuation Ratios EYES's Financial Strength Ratios EYES's Dividend Payout Ratio
EYES's Roa EYES's Inventory Turnover Ratio EYES's Growth Rates EYES's Dividend Comparisons



Companies with similar Revenue doubling for the quarter ending Jun 30 2017 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2017
Orexigen Therapeutics, Inc.  199.78 %$ 199.782 millions
Enzon Pharmaceuticals, Inc.  198.20 %$ 198.195 millions
Cytomx Therapeutics, Inc.  182.87 %$ 182.870 millions
Regenxbio Inc.  176.29 %$ 176.295 millions
Hci Viocare  175.23 %$ 175.234 millions
Exact Sciences Corp  172.11 %$ 172.108 millions
Ionis Pharmaceuticals Inc  170.74 %$ 170.736 millions
Novavax Inc  168.74 %$ 168.743 millions
Invitae Corp  156.87 %$ 156.872 millions
Biolargo, Inc.  156.45 %$ 156.446 millions
Rewalk Robotics Ltd.  145.65 %$ 145.655 millions
Viewray, Inc.  133.44 %$ 133.445 millions
Second Sight Medical Products Inc  115.62 %$ 115.622 millions
Novocure Ltd  114.16 %$ 114.164 millions
Geovax Labs, Inc.  111.77 %$ 111.774 millions
Kite Pharma, Inc.  109.64 %$ 109.635 millions
U.s. Stem Cell, Inc.  104.34 %$ 104.345 millions
Innovus Pharmaceuticals, Inc.  99.96 %$ 99.962 millions
Adamis Pharmaceuticals Corp  97.36 %$ 97.363 millions
Biocept Inc  92.95 %$ 92.946 millions
Dimension Therapeutics, Inc.  84.27 %$ 84.268 millions
Egalet Corp  81.30 %$ 81.304 millions
Dariohealth Corp.  80.87 %$ 80.867 millions
Innoviva, Inc.  80.35 %$ 80.346 millions
Corcept Therapeutics Inc  80.28 %$ 80.283 millions
Mri Interventions, Inc.  79.01 %$ 79.005 millions
Anavex Life Sciences Corp.  77.18 %$ 77.175 millions
China Yct International Group, Inc.  76.42 %$ 76.421 millions
Pieris Pharmaceuticals, Inc.  72.70 %$ 72.702 millions
Omeros Corp  71.44 %$ 71.441 millions